Skip to main content
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · IEX Real-Time Price · USD
15.50
+0.27 (1.77%)
At close: May 1, 2024, 4:00 PM
16.22
+0.72 (4.65%)
After-hours: May 1, 2024, 7:45 PM EDT

Arcus Biosciences Revenue

In the year 2023, Arcus Biosciences had annual revenue of $117.00M with 4.46% growth. Revenue in the quarter ending December 31, 2023 was $31.00M, a -8.82% decrease year-over-year.

Revenue (ttm)
$117.00M
Revenue Growth
+4.46%
P/S Ratio
12.05
Revenue / Employee
$202,773
Employees
577
Market Cap
1.41B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agiliti 1.17B
National HealthCare 1.14B
Warby Parker 669.77M
InMode 492.05M
ANI Pharmaceuticals 486.82M
Canopy Growth 248.53M
LeMaitre Vascular 193.48M
Revenue Rankings

RCUS News

More News